ArticleCancers2026

New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis.

Vanessa L Merker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.